These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33061416)

  • 1. Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer.
    Ye S; Xu Y; Wang L; Zhou K; He J; Lu J; Huang Q; Sun P; Wang T
    Onco Targets Ther; 2020; 13():8887-8899. PubMed ID: 33061416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status.
    Ye S; Xu Y; Li J; Zheng S; Sun P; Wang T
    Endocr Connect; 2019 Jun; 8(6):661-671. PubMed ID: 30999280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
    Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.
    Wu YM; Chen ZJ; Liu H; Wei WD; Lu LL; Yang XL; Liang WT; Liu T; Liu HL; Du J; Wang HS
    Oncotarget; 2015 Sep; 6(28):25588-601. PubMed ID: 26160845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPER-regulated lncRNA-Glu promotes glutamate secretion to enhance cellular invasion and metastasis in triple-negative breast cancer.
    Yin J; Tu G; Peng M; Zeng H; Wan X; Qiao Y; Qin Y; Liu M; Luo H
    FASEB J; 2020 Mar; 34(3):4557-4572. PubMed ID: 32030797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
    Sjöström M; Hartman L; Grabau D; Fornander T; Malmström P; Nordenskjöld B; Sgroi DC; Skoog L; Stål O; Leeb-Lundberg LM; Fernö M
    Breast Cancer Res Treat; 2014 May; 145(1):61-71. PubMed ID: 24715381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer.
    Zhang D; Chen H; Wang J; Ji J; Imam M; Zhang Z; Yan S
    Front Cell Dev Biol; 2024; 12():1338448. PubMed ID: 38476263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes.
    Xu T; Ma D; Chen S; Tang R; Yang J; Meng C; Feng Y; Liu L; Wang J; Luo H; Yu K
    NPJ Breast Cancer; 2022 Aug; 8(1):100. PubMed ID: 36042244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of GPER promoting proliferation, migration and invasion of triple-negative breast cancer cells through CAF.
    Yang K; Yao Y
    Am J Transl Res; 2019; 11(9):5858-5868. PubMed ID: 31632554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
    Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer.
    Manna S; Bostner J; Sun Y; Miller LD; Alayev A; Schwartz NS; Lager E; Fornander T; Nordenskjöld B; Yu JJ; Stål O; Holz MK
    Clin Cancer Res; 2016 Mar; 22(6):1421-31. PubMed ID: 26542058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enhanced expression of estrogen-related receptor α in human bladder cancer tissues and the effects of estrogen-related receptor α knockdown on bladder cancer cells.
    Ye X; Guo J; Zhang H; Meng Q; Ma Y; Lin R; Yi X; Lu H; Bai X; Cheng J
    J Cell Biochem; 2019 Aug; 120(8):13841-13852. PubMed ID: 30977157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
    Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
    Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
    Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
    Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis.
    Huang R; Li J; Pan F; Zhang B; Yao Y
    Am J Transl Res; 2020; 12(1):32-44. PubMed ID: 32051735
    [No Abstract]   [Full Text] [Related]  

  • 19. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
    Tao S; He H; Chen Q; Yue W
    Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
    Han L; Liu B; Jiang L; Liu J; Han S
    Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.